THE TYPE-II DECOY RECEPTOR - A NOVEL REGULATORY PATHWAY FOR INTERLEUKIN-1

被引:315
作者
COLOTTA, F
DOWER, SK
SIMS, JE
MANTOVANI, A
机构
[1] UNIV BRESCIA,DEPT BIOTECHNOL,PATHOL SECT,I-25123 BRESCIA,ITALY
[2] IMMUNEX RES & DEV CORP,SEATTLE,WA 98101
来源
IMMUNOLOGY TODAY | 1994年 / 15卷 / 12期
关键词
D O I
10.1016/0167-5699(94)90217-8
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The interleukin 1 (IL-1) system plays a central role in inflammation and immunity. Of the two receptors that bind IL-1, the type I receptor is known to mediate signaling activity: whereas the function of the type II receptor remains unknown. Here, Francesco Colotta and colleagues review the properties of these receptors and summarize evidence indicating that the type II receptor acts as a regulated decoy target for IL-1.
引用
收藏
页码:562 / 566
页数:5
相关论文
共 47 条
[11]   INTERLEUKIN-1 TYPE-II RECEPTOR - A DECOY TARGET FOR IL-1 THAT IS REGULATED BY IL-4 [J].
COLOTTA, F ;
RE, F ;
MUZIO, M ;
BERTINI, R ;
POLENTARUTTI, N ;
SIRONI, M ;
GIRI, JG ;
DOWER, SK ;
SIMS, JE ;
MANTOVANI, A .
SCIENCE, 1993, 261 (5120) :472-475
[12]  
COLOTTA F, 1992, BLOOD, V80, P2012
[13]  
COLOTTA F, 1993, BLOOD, V81, P1347
[14]  
COLOTTA F, 1994, J BIOL CHEM, V269, P12403
[15]   T-CELL INTERLEUKIN-1 RECEPTOR CDNA EXPRESSED IN CHINESE-HAMSTER OVARY CELLS REGULATES FUNCTIONAL-RESPONSES TO INTERLEUKIN-1 [J].
CURTIS, BM ;
GALLIS, B ;
OVERELL, RW ;
MCMAHAN, CJ ;
DEROOS, P ;
IRELAND, R ;
EISENMAN, J ;
DOWER, SK ;
SIMS, JE .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (09) :3045-3049
[16]   MODALITIES FOR REDUCING INTERLEUKIN-1 ACTIVITY IN DISEASE (REPRINTED FROM TRENDS IN PHARMACOLOGICAL SCIENCES, VOL 14, PG 155-159, 1993) [J].
DINARELLO, CA .
IMMUNOLOGY TODAY, 1993, 14 (06) :260-264
[17]  
DINARELLO CA, 1991, BLOOD, V77, P1627
[18]   INCREASED EXPRESSION OF THE INTERLEUKIN-1 RECEPTOR ON BLOOD NEUTROPHILS OF HUMANS WITH THE SEPSIS SYNDROME [J].
FASANO, MB ;
COUSART, S ;
NEAL, S ;
MCCALL, CE .
JOURNAL OF CLINICAL INVESTIGATION, 1991, 88 (05) :1452-1459
[19]  
FILSON AJ, 1993, DEVELOPMENT, V118, P731
[20]  
FOXWELL BMJ, 1992, CLIN EXP IMMUNOL, V90, P161